ANTIBODY COMPOSITIONS

The present invention relates to a (bio) pharmaceutical composition, in particular to a liquid (e.g., aqueous) biopharmaceutical composition, and more particularly to a liquid biopharmaceutical composition comprising an anti-EGFR/anti-LGR5 bispecific antibody. The invention also relates to a method...

Full description

Saved in:
Bibliographic Details
Main Authors ALVENTE TUDOR, BAKKER ALEXANDER BERTHOLD HENDRIK, HENDRIKS LINDA JOHANNA ALEIDA, DALPIN, GUILLAUME, DESIREE, POIRIER, EMILY, BRIGITTE, DOORNBOS, ROBERT, PAUL
Format Patent
LanguageChinese
English
Published 22.09.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a (bio) pharmaceutical composition, in particular to a liquid (e.g., aqueous) biopharmaceutical composition, and more particularly to a liquid biopharmaceutical composition comprising an anti-EGFR/anti-LGR5 bispecific antibody. The invention also relates to a method of making the composition; a kit comprising the composition; a package comprising the composition; a method of manufacturing the package; and therapeutic methods of using the compositions and/or packages, particularly for cancer treatment, such as for the treatment of colorectal cancer. 本发明涉及一种(生物)医药组合物,尤其涉及一种液体(例如水性)生物医药组合物,更尤其涉及一种包含抗EGFR/抗LGR5双特异性抗体的液体生物医药组合物。本发明还涉及一种制造该组合物的方法;一种包括该组合物的试剂盒;一种包括该组合物的包装;一种制造该包装的方法;及使用该组合物及/或包装尤其进行癌症治疗,例如用于治疗结肠直肠癌的治疗方法。
Bibliography:Application Number: CN202180092920